AI assistant
Sending…
AYTU BIOPHARMA, INC — Director's Dealing 2016
Apr 13, 2016
35030_dirs_2016-04-13_003eb43d-bba6-4a57-8317-ca4b0c472162.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AYTU BIOSCIENCE, INC (AYTU)
CIK: 0001385818
Period of Report: 2016-04-11
Reporting Person: DOCKERY CARL (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-11 | Employee Stock Option Grant | $0.56 | A | 100000 | Acquired | 2026-04-10 | Common Stock (100000) | Direct |
More from AYTU BIOPHARMA, INC
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 13
Earnings Release
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Investor Presentation
2026
Jan 20
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 10
Major Shareholding Notification
2025
Nov 14
Interim / Quarterly Report
2025
Nov 13
Earnings Release
2025
Nov 13
Major Shareholding Notification
2025
Nov 12